共 224 条
[1]
Verges B(2022)Liraglutide reduces plasma PCSK9 in patients with type 2 Diabetes not treated with statins Diabetes Metab 48 101284-53
[2]
Hassid J(2022)PCSK9 contributes to the cholesterol, glucose, and Insulin2 homeostasis in Seminiferous Tubules and maintenance of Immunotolerance in Testis Front Cell Dev Biol 10 889972-53
[3]
Rouland A(2022)Effect of Evolocumab in patients with prior percutaneous coronary intervention Circ Cardiovasc Interv 15 e011382-91
[4]
Bouillet B(2016)Variation in PCSK9 and HMGCR and risk of Cardiovascular Disease and Diabetes N Engl J Med 375 2144-8
[5]
Simoneau I(2022)Elevated lipoprotein(a) and genetic polymorphisms in the LPA gene may predict cardiovascular events Sci Rep 12 3588-6
[6]
Petit JM(2022)Influence of circulating nesfatin-1, GSH and SOD on insulin secretion in the development of T2DM Front Public Health 10 882686-68
[7]
Pelletier RM(2004)Global prevalence of Diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 1047-7
[8]
Layeghkhavidaki H(2016)Association between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and risk of type 2 Diabetes: a Meta-analysis JAMA 316 1383-51
[9]
Seidah NG(2008)Cholesterol in islet dysfunction and type 2 Diabetes J Clin Invest 118 403-93
[10]
Prat A(2003)Mutations in PCSK9 cause autosomal dominant hypercholesterolemia Nat Genet 34 154-95